International Journal of Clinical Oncology
Papers 3054
1 page of 306 pages (3,054 results)
#1Elwira Szychot (The Royal Marsden NHS Foundation Trust)H-Index: 1
#2Daniel A. Morgenstern (Hospital for Sick Children)H-Index: 1
Last. Lorenzo Biassoni (Great Ormond Street Hospital for Children NHS Foundation Trust)H-Index: 7
view all 10 authors...
Background null More than 50% children with high-risk neuroblastoma (HR-NBL) experience disease progression, which we hypothesise is due to non-response of primary tumour to treatment. Current imaging techniques are unable to characterise response in primary tumour (necrotic versus viable tissue) at diagnosis or follow-up. null Objectives null Compare clinico-histological characteristics between primary 123ImIBG-avid tumours that became entirely 123ImIBG-non-avid (responders) after induction che...
#1Linhui Zhu (Fudan University)
#2Huan Li (Fudan University)H-Index: 2
Last. Qing Zhai (Fudan University)H-Index: 6
view all 7 authors...
This study aimed to investigate risk factors associated with oxaliplatin hypersensitivity reactions in cancer patients through a meta-analysis. A comprehensive retrieve of Chinese databases China National Knowledge Infrastructure, Wanfang Data, VIP Database and English databases PubMed, ScienceDirect, Embase and Cochrane library was conducted. The studies that meet the requirements for meta-analysis according to inclusion and exclusion criteria were screened and assessed for eligibility. Odds ra...
#1Thomas O'Keefe (UCSD: University of California, San Diego)H-Index: 2
#2Olivier Harismendy (UCSD: University of California, San Diego)H-Index: 29
Last. Anne M. Wallace (UCSD: University of California, San Diego)H-Index: 31
view all 3 authors...
PURPOSE Trials for DCIS have not explored whether outcomes for patients with large disease burden requiring mastectomy are comparable to those of patients with lumpectomy-amenable disease. We aim to identify whether patients with DCIS larger than 5 cm and diffuse-type DCIS differ in breast cancer mortality (BCM) from patients with disease less than 5 cm. METHODS Patients diagnosed with DCIS in the SEER program were assessed to identify factors prognostic of breast-cancer-specific survival using ...
#1Dachuan Zhang (Soochow University (Suzhou))H-Index: 8
#2X Gao (Soochow University (Suzhou))H-Index: 1
Last. Qing Li (Soochow University (Suzhou))H-Index: 7
view all 5 authors...
PD-L1 expression in tumor cells can predict the efficacy of PD-1/PD-L1 inhibitors and prognosis in patients. However, the correlation between the PD-L1 expression and the novel lung adenocarcinoma classification are obscure. 94 lung adenocarcinoma cases were reviewed in the Third Affiliated Hospital of Soochow University from January to December 2019. PD-L1 (DAKO 22C3) was used to test the PD-L1 expression in lung cancer tissue. TPS was used to interpret the PD-L1 expression. The negative, low p...
#1Ryutaro Shimizu (Tottori University)H-Index: 1
#2Masashi Honda (Tottori University)H-Index: 11
Last. Atsushi Takenaka (Tottori University)H-Index: 30
view all 10 authors...
Sarcopenia impacts perioperative outcomes and prognosis in various carcinomas. We aimed to investigate whether sarcopenia at the time of chemotherapy induction in patients with urothelial carcinoma is associated with prognosis. We evaluated patients treated with chemotherapy for urothelial carcinoma between April 2013 and February 2018 at our institution and affiliated centers. Skeletal muscle mass (total psoas muscle, paraspinal muscle, and total skeletal muscle areas) were used to calculate th...
#1Yoichiro Tohi (Kagawa University)H-Index: 4
#2Takuma Kato (Kagawa University)H-Index: 5
Last. Hirohito NaitoH-Index: 1
view all 20 authors...
This study aimed to evaluate the pathological findings and oncological outcomes of deferred radical prostatectomy in patients who initially elected for active surveillance in a Japanese cohort. We retrospectively analyzed data collected from a multi-institutional prospective observational cohort of the Prostate Cancer Research International: Active Surveillance-JAPAN study between January 2010 and September 2020. Triggers for radical prostatectomy were disease progression based on pathological f...
#1Fumihiko Urabe (Jikei University School of Medicine)H-Index: 8
#2Takahiro Kimura (Jikei University School of Medicine)H-Index: 20
Last. Kenta Miki (Jikei University School of Medicine)H-Index: 15
view all 11 authors...
Previous studies have demonstrated excellent overall outcomes in patients who underwent low-dose-rate brachytherapy (LDR-BT) in intermediate-risk, localized prostate cancer (PCa). We thus investigated the appropriate length of time before completing prostate-specific antigen (PSA) monitoring after treatment. Between 2003 and 2014, 710 localized, intermediate-risk PCa patients underwent LDR-BT with or without supplemental external beam radiotherapy (EBRT). Data from 567 of those patients was anal...
1 CitationsSource
#1Shinsuke Iida (Nagoya City University)H-Index: 53
#2Tohru IzumiH-Index: 45
Last. Makoto Sasaki (Juntendo University)H-Index: 15
view all 10 authors...
TOURMALINE-MM1 was a global study that demonstrated a significant improvement in progression-free survival with ixazomib plus lenalidomide and dexamethasone compared with placebo plus lenalidomide and dexamethasone, in patients with relapsed and/or refractory multiple myeloma. The current study was conducted to evaluate further the efficacy and safety of ixazomib plus lenalidomide and dexamethasone in Japanese patients. This phase 2, open-label, single-arm, multicenter study enrolled patients ag...
#1Hiroki Hori (Mie University)H-Index: 18
#2Asuka Ohta (Mie University)
Last. Kosuke Kurihara (Mie University)
view all 13 authors...
The practice of cancer diagnosis disclosure to children has been changed with the times. The regulations of clinical trials in the 2000s might change the practice in Japan. However, the perspective of this topic among children and adults has not been investigated in detail. We studied changes in the practice of information sharing with children with cancer at pediatric cancer centers and the perspective of cancer diagnosis disclosure to children among school children, their parents and pediatric...
#1Koji Kato (Kyushu University)H-Index: 52
#2Shinichi MakitaH-Index: 12
Last. Natsuko Fukuda (Daiichi Sankyo)
view all 18 authors...
Axicabtagene ciloleucel (axi-cel) is an autologous chimeric antigen receptor T-cell based anti-CD19 therapy. The ZUMA-1 study, multicenter, single-arm, registrational Phase 1/2 study of axi-cel demonstrated high objective response rate in patients with relapsed/refractory large B-cell lymphoma. Here, we present the results of the bridging study to evaluate the efficacy and safety of axi-cel in Japanese patients (JapicCTI-183914). This study was the phase 2, multicenter, open-label, single-arm tr...
Top fields of study
Surgical oncology
General surgery